Reply to Manian

Jason M Pogue^{1

2}, Bhagyashri Navalkele², Keith S Kaye³

Affiliations

¹ Department of Pharmacy Services, Sinai-Grace Hospital, Detroit Medical Center.
² Wayne State University School of Medicine, Detroit.
³ Department of Medicine, University of Michigan Medical School, Ann Arbor.

Comment

Jason M Pogue et al. Clin Infect Dis. 2017.

. 2017 Jul 1;65(1):178-179.

doi: 10.1093/cid/cix322.

Jason M Pogue^{1

2}, Bhagyashri Navalkele², Keith S Kaye³

¹ Department of Pharmacy Services, Sinai-Grace Hospital, Detroit Medical Center.
² Wayne State University School of Medicine, Detroit.
³ Department of Medicine, University of Michigan Medical School, Ann Arbor.

No abstract available

Comment on

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
Navalkele B, Pogue JM, Karino S, Nishan B, Salim M, Solanki S, Pervaiz A, Tashtoush N, Shaikh H, Koppula S, Koons J, Hussain T, Perry W, Evans R, Martin ET, Mynatt RP, Murray KP, Rybak MJ, Kaye KS. Navalkele B, et al. Clin Infect Dis. 2017 Jan 15;64(2):116-123. doi: 10.1093/cid/ciw709. Epub 2016 Oct 20. Clin Infect Dis. 2017. PMID: 27986669
Should We Revisit the Nephrotoxic Potential of Piperacillin-Tazobactam as Well?
Manian FA. Manian FA. Clin Infect Dis. 2017 Jul 1;65(1):178. doi: 10.1093/cid/cix321. Clin Infect Dis. 2017. PMID: 28419199 No abstract available.